Company Aimmune Therapeutics, Inc.
Equities
AIMT
US00900T1079
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | 57 | 20-09-30 | |
Samina Bari
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,450,142 | 50,930,993 ( 77.82 %) | 0 | 77.82 % |
Company contact information
Aimmune Therapeutics, Inc.
1007 US Highway 202/206 Building JR2
08807, Bridgewater
+650 614 5220
http://www.aimmune.com![address Aimmune Therapeutics, Inc.(AIMT)](https://cdn.zonebourse.com/static/address/23306014.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |